Invention Grant
- Patent Title: Selective inhibitors of c-Fos and their antiproliferative properties
-
Application No.: US15302814Application Date: 2015-04-08
-
Publication No.: US10053502B2Publication Date: 2018-08-21
- Inventor: Peter Vanhoutte , Jocelyne Caboche
- Applicant: INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) , CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE—CNRS
- Applicant Address: FR Paris FR Paris
- Assignee: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM),CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
- Current Assignee: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM),CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
- Current Assignee Address: FR Paris FR Paris
- Agency: Buchanan Ingersoll & Rooney, PC
- Priority: EP14305512 20140408
- International Application: PCT/EP2015/057588 WO 20150408
- International Announcement: WO2015/155218 WO 20151015
- Main IPC: A61K38/00
- IPC: A61K38/00 ; C07K14/82 ; A61K38/17 ; C07K14/47
Abstract:
Selective inhibitor of c-Fos and their antiproliferative properties The invention relates to selective inhibitor of c-Fos for use in the prevention and/or treatment of cancers and restenosis.
Public/Granted literature
- US20170029487A1 SELECTIVE INHIBITORS OF C-FOS AND THEIR ANTIPROLIFERATIVE PROPERTIES Public/Granted day:2017-02-02
Information query
IPC分类:
